Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.
about
Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsSitagliptin improves albuminuria in patients with type 2 diabetes mellitus.The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry.Cause-specific mortality according to urine albumin creatinine ratio in the general population.Normal range albuminuria and metabolic syndrome in South Korea: the 2011-2012 Korean National Health and Nutrition Examination Survey.Diabetic nephropathy: What does the future hold?A remote cis-acting variant at 3q links glomerular NCK1 to diabetic nephropathy.Diagnostic efficacy of random albumin creatinine ratio for detection of micro and macro-albuminuria in type 2 diabetes mellitus.Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetesWest Meets East.Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney diseaseLong-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.Does albuminuria predict renal risk and/or cardiovascular risk in obese type 2 diabetic patients?Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency.Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes.Novel urinary biomarkers in early diabetic kidney disease.Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes.Novel effective drugs for diabetic kidney disease? or not?Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.Novel Biomarkers for Renal Diseases? None for the Moment (but One).Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study.Diabetes: Legacy effects of RAS blockade in diabetes mellitus.Heart rate-corrected QT interval is a novel risk marker for the progression of albuminuria in people with Type 2 diabetes.Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes.
P2860
Q27010669-40E930D9-3EE3-48E0-8308-167C79E01856Q33608090-6EB22E23-E1FB-4EA4-9876-8CC74E54DA3DQ34297130-997F89F8-45BE-43B0-8FEF-7206DE69F125Q35050397-D480E8CC-B45D-44E3-9322-B3F217FB60FCQ35133466-F4EC1155-29AA-40A5-85F3-33733556101FQ35610944-68E7F0CB-C142-4C1F-9D34-2DDDE58DF3E4Q36441616-D57F907E-64A6-4B5C-B261-ECF170E62E2DQ36618478-2619071C-DE47-4D95-A9FE-117D9A1D6FBAQ36709462-8FED4549-AFB3-46A6-8446-E25BFFAC1251Q36942154-B8C1AD46-372E-4BA1-B070-765D23A59693Q37069890-3A0E2F20-406B-4938-8F7D-B1ADA5700053Q37219039-F759B292-FFEB-4C22-8FA0-A8C68F943B44Q37278008-B5A39FCC-4109-43B0-8A33-769118836048Q37587312-3F30D587-D32A-45B0-A6FB-1108DBDAE534Q38148018-E59858CD-C52F-4D21-ADFA-C7113E8C483CQ38153194-69CF176F-136C-4349-AC6F-F2B0DB460038Q38219572-F17952B4-FA54-4E7C-A7E3-25C2F54AC1A1Q38235903-3D72DAC8-913C-4BFB-BD40-19757B0D8E5CQ38265818-6A41AC6A-7686-4DFD-A077-CE78BE1CBD6BQ38384167-FC1564E3-8BBF-450A-BF08-8D8F86AECEE1Q38763898-9711589A-3D1E-41B5-8FB2-660BCB77C90EQ40322521-86679D23-A579-4CCE-BA27-3AF6F7350129Q40721152-B25F0377-0B9B-47ED-8C5E-B44D7949E760Q44524819-A9152B3F-4A17-4C23-9A2D-9FDDA1485001Q48226183-1C17D7EB-46C0-4C2E-AA41-1007E9A9A881Q50851996-DE8036B8-DE45-4676-9B64-BCF77865C82DQ53854006-B1C272A2-FF36-4F62-AAED-C0313CA18C88
P2860
Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@ast
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@en
type
label
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@ast
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@en
prefLabel
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@ast
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@en
P2093
P2860
P50
P356
P1476
Measurable urinary albumin pre ...... patients with type 2 diabetes.
@en
P2093
Alessandro Roberto Dodesini
Aneliya Parvanova Ilieva
BENEDICT Study Investigators
Enrica Capitoni
Esteban Porrini
Flavio Gaspari
Giuseppe Sampietro
Ilian Petrov Iliev
Nadia Rubis
Nicola Motterlini
P2860
P304
P356
10.1681/ASN.2012030252
P577
2012-08-30T00:00:00Z